News Archive
Rhythm announced today the initiation of the first of a series of clinical trials with RM-493, the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of obesity in individuals with a genetic deficiency in the MC4R pathway.
Cell Therapeutics, Inc. (CTI) announced today that it concluded an agreement with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) in Germany for PIXUVRI® (pixantrone).
At the forefront of technological advancement, Omnicell UK & Ireland, has launched a new automated pharmacy packaging and filling solution which will help community pharmacy to drive efficiencies in the face of major funding cuts. The Omnicell VBM 200F will help to reinforce the company's reputation as a world-leading provider of automated healthcare solutions and medication adherence packaging.
Biomet, Inc. announced today fourth quarter and fiscal year 2010 preliminary net sales results for the year ended May 31, 2010.
› Verified 5 days ago